Since glial pathology is one of the hallmarks of ALS [33], [34], [35], we tested whether administration of PBS57 affected astrocyte activation, by staining for glial fibrillary acidic protein (GFAP). Here, GFAP is linked to amyotrophic lateral sclerosis.